Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

ImmuLogic licenses antiallergy products from Sankyo

May 28, 1998

New respiratory therapeutics in development at Byk Gulden

May 27, 1998

Human leukocyte elastase inhibitors in development at Sanofi

May 26, 1998

Sepracor receives patent covering single isomer of the antihistamine cetirizine

May 26, 1998

VUF-5087, a structurally rigid CysLT1 receptor antagonist

May 22, 1998

Research at Kowa leads to potent inhibitors of IgE antibody production

May 21, 1998

Merck KGaA synthesizes new series of PDE IV inhibitors

May 21, 1998

Celgene claims agents for reducing cytokine levels

May 20, 1998

New PDE IV inhibitors from Euroceltique

May 19, 1998

Rhone-Poulenc Rorer submits NDA for ebastine in U.S.

May 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...